Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
Queensland Health
Covington
US Army
Deloitte
Boehringer Ingelheim
Johnson and Johnson
Fish and Richardson

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,858,740

« Back to Dashboard

Title:Exendin agonist compounds
Abstract: Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would be benefited by lower plasma glucose and delaying and/or slowing gastric emptying.
Inventor(s): Beeley; Nigel Robert Arnold (La Jolla, CA), Prickett; Kathryn S. (San Francisco, CA)
Assignee: Amylin Pharmaceuticals, Inc. (San Diego, CA)
Filing Date:Aug 28, 2006
Application Number:11/511,738
Claims:1. A peptide comprising the amino acid sequence of SEQ ID NO:5.

2. The peptide of claim 1 in the form of a pharmaceutically acceptable salt.

3. A composition comprising the peptide of claim 1 and a pharmaceutically acceptable carrier.

4. A peptide comprising the amino acid sequence of SEQ ID NO: 37, 31, or 32.

5. The peptide of claim 4 in the form of a pharmaceutically acceptable salt.

6. A composition comprising the peptide of claim 4 and a pharmaceutically acceptable carrier.

7. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:37.

8. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:31.

9. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:32.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Colorcon
Julphar
Fish and Richardson
Deloitte
Cerilliant
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.